Bio-Techne Corporation
72.25USD
-0.0600 (-0.08%)
Fetching financial statements from SEC filings…
| In $M except per-share | Q4 FY26* | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25* | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 321 | 311 | 296 | 287 | 317 | 316 | 297 | 289 |
| Cost of Revenue | 110 | 103 | 105 | 98 | 118 | 102 | 103 | 106 |
| Gross Profit | 211 | 208 | 191 | 188 | 199 | 215 | 194 | 183 |
| Operating Income | 74 | 75 | 54 | 48 | -24 | 39 | 47 | 40 |
| Net Income | 55 | 51 | 38 | 38 | -18 | 23 | 35 | 34 |
| EPS (Diluted) | $0.35 | $0.32 | $0.24 | $0.24 | $-0.11 | $0.14 | $0.22 | $0.21 |
* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)